Two Years Follow up of Domain Specific Cognitive Training in Relapsing Remitting Multiple Sclerosis: A Randomized Clinical Trial

Cognitive Training ◽

Domain Specific ◽

Relapsing Remitting ◽

A non‐randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing‐remitting multiple sclerosis patients

Clinical and Translational Medicine ◽

10.1186/s40169-019-0228-7 ◽

2019 ◽

Vol 8 (1) ◽

Author(s):

Mehrdokht Mazdeh ◽

Shahriar Kargar Monhaser ◽

Mohammad Taheri ◽

Soudeh Ghafouri‐Fard

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Scale Score ◽

Expanded Disability Status Scale ◽

Disability Status ◽

Relapsing Remitting ◽

Multiple Sclerosis Patients ◽

LB003-MON ORAL NUTRACEUTICAL FORMULA (PLP10) FOR THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS: DOUBLE-BLIND, RANDOMIZED CLINICAL TRIAL

Clinical Nutrition Supplements ◽

10.1016/s1744-1161(12)70661-0 ◽

2012 ◽

Vol 7 (1) ◽

pp. 266

Author(s):

I.S. Patrikios ◽

M.C. Pantzaris ◽

G.N. Loukaides ◽

E.E. Ntzani

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Double Blind ◽

Relapsing Remitting ◽

Effects of photobiomodulation on interleukin-10 and nitrites in individuals with relapsing-remitting multiple sclerosis – Randomized clinical trial

PLoS ONE ◽

10.1371/journal.pone.0230551 ◽

2020 ◽

Vol 15 (4) ◽

pp. e0230551

Author(s):

Tamiris Silva ◽

Yara Dadalti Fragoso ◽

Maria Fernanda Setúbal Destro Rodrigues ◽

Andréa Oliver Gomes ◽

Fernanda Cordeiro da Silva ◽

...

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Interleukin 10 ◽

Relapsing Remitting ◽

Comparing efficacy and side effects of a weekly intramuscular biogeneric/biosimilar interferon beta-1a with Avonex in relapsing remitting multiple sclerosis: A double blind randomized clinical trial

Clinical Neurology and Neurosurgery ◽

10.1016/j.clineuro.2012.02.039 ◽

2012 ◽

Vol 114 (7) ◽

pp. 986-989 ◽

Cited By ~ 8

Author(s):

Shahriar Nafissi ◽

Amirreza Azimi ◽

Ali Amini-Harandi ◽

Shiva Salami ◽

Mohammad Amir shahkarami ◽

...

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Side Effects ◽

Interferon Beta ◽

Double Blind ◽

Relapsing Remitting ◽

Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial

American Journal of Clinical Nutrition ◽

10.3945/ajcn.113.075309 ◽

2015 ◽

Vol 101 (3) ◽

pp. 487-495 ◽

Cited By ~ 30

Author(s):

Anja Mähler ◽

Jochen Steiniger ◽

Markus Bock ◽

Lars Klug ◽

Nadine Parreidt ◽

...

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Metabolic Response ◽

Relapsing Remitting ◽

RESULTS OF AN OPEN-LABEL COMPARATIVE RANDOMIZED CLINICAL TRIAL OF AXOGLATIRAN® FS (F-SINTEZ, RUSSIA) EFFICIENCY AND SAFETY IN COMPARISON WITH COPAXONE®-TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD., ISRAEL) IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS

Neuromuscular Diseases ◽

10.17650/2222-8721-2016-6-4-28-36 ◽

2016 ◽

Vol 6 (4) ◽

pp. 28-36 ◽

Cited By ~ 3

Author(s):

F. A. Khabirov ◽

T. I. Khaibullin ◽

E. V. Granatov ◽

N. N. Babicheva ◽

L. A. Aver’yanova ◽

...

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Open Label ◽

Relapsing Remitting ◽

Pharmaceutical Industries ◽

The effects of modified anti-inflammatory diet on fatigue, quality of life, and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: a randomized clinical trial

International Journal of Neuroscience ◽

10.1080/00207454.2020.1750398 ◽

2020 ◽

pp. 1-9

Author(s):

Zahra Mousavi-Shirazi-Fard ◽

Zohreh Mazloom ◽

Sadegh Izadi ◽

Mohammad Fararouei

Keyword(s):

Quality Of Life ◽

Multiple Sclerosis ◽

Clinical Trial ◽

Inflammatory Biomarkers ◽

Relapsing Remitting ◽

Multiple Sclerosis Patients ◽

Efficacy of Delayed-release Dimethyl Fumarate in Newly Diagnosed Patients With Relapsing-Remitting Multiple Sclerosis: Eight-Year Follow-up of an Integrated Analysis of DEFINE, CONFIRM, and ENDORSE

10.26226/morressier.59a3eda8d462b8028d895222 ◽

2017 ◽

Cited By ~ 1

Author(s):

Ralf Gold

Keyword(s):

Multiple Sclerosis ◽

Dimethyl Fumarate ◽

Integrated Analysis ◽

Newly Diagnosed ◽

Delayed Release ◽

Relapsing Remitting ◽

Effects of hippotherapy on postural balance, functional mobility, self-perceived fatigue, and quality of life in people with relapsing-remitting multiple sclerosis: Secondary results of an exploratory clinical trial

Multiple Sclerosis and Related Disorders ◽

10.1016/j.msard.2021.102948 ◽

2021 ◽

pp. 102948

Author(s):

Andréa Gomes Moraes ◽

Silvia G.R. Neri ◽

Robert W. Motl ◽

Carlos Bernardo Tauil ◽

Felipe von Glehn ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Sclerosis ◽

Clinical Trial ◽

Postural Balance ◽

Functional Mobility ◽

Relapsing Remitting ◽

Relapsing Remitting Multiple Sclerosis ◽

Secondary Results

Corrigendum to “Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years’ Follow-up of DEFINE, CONFIRM, and ENDORSE”

Therapeutic Advances in Neurological Disorders ◽

10.1177/1756286420968357 ◽

2020 ◽

Vol 13 ◽

pp. 175628642096835

Keyword(s):

Multiple Sclerosis ◽

Dimethyl Fumarate ◽

Safety And Efficacy ◽

Delayed Release ◽

Relapsing Remitting ◽